Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome

• Status: Completed
• Trial end date: 2011-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

Polycystic ovarian syndrome (PCOS) is the most common cause of anovulatory infertility and causes menstrual disruption in 6.6-6.8% of women in reproductive age and is characterized by insulin resistance, hyperinsulinemia, hyperandrogenism and anovulation. The gaol of this study was to assess the effects of metformin on menstrual disorders and lipid profile in women with PCOS in bandarabbas.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hormozgan University of Medical Sciences
• Treatments: Metformin

Criteria

Inclusion Criteria:

• Women with PCOS

Exclusion Criteria:

• avoiding to participate in the study